Liver and kidney toxicity induced by Afzal smokeless tobacco product in Oman

Nawal Al-Mukhaini, Taher Ba-Omar, Elsadig Eltayeb, Aisha Al-Shihi, Nafila Al-Riyami, Jamila Al-Belushi, Kawthar Al-Adawi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Afzal, the common smokeless tobacco product (STP) in Oman, is believed to contain toxins that may impair the function of some organs such as liver and kidney. An aqueous extract from Afzal was added to drinking water to be administrated orally to Wistar albino rats (n = 72) young and adult from both genders weighing between 60-80. g and 150-240. g respectively for 8 weeks. Animals were divided into three groups: control (distilled water instead of Afzal extract), low-dose (3. mg. nicotine/kg. body. weight/day) and high-dose (6. mg. nicotine/kg. body. weight/day). The animals were euthanized and their blood, liver and kidney were collected for biochemical and histopathological investigations. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were assayed for the liver function, while blood urea nitrogen (BUN) and creatinine (CRT) were assayed for the kidney function. The results showed a significant increase in the ALT, AST, BUN and CRT levels (P <. 0.05) in both Afzal-treated groups (low and high doses) compared with the control. Histopathological findings revealed the initial but seem to be serious degenerative alterations of periportal fibrosis in liver and edematous and calcified changes in renal glomerulus among Afzal-treated groups. Additionally, the weight gain of the Afzal-treated groups was lower than the control group. Our findings show that the exposure of Wistar rats to the Afzal extract has the potentials of causing decreased weight gain and dose-dependent functional and structural damage to the biochemical and histological profiles of liver and kidney as well as serious biochemical effects.

Original languageEnglish
JournalTissue and Cell
DOIs
Publication statusAccepted/In press - Aug 31 2016

Fingerprint

Oman
Smokeless Tobacco
Tobacco Products
Kidney
Liver
Blood Urea Nitrogen
Aspartate Aminotransferases
Alanine Transaminase
Nicotine
Weight Gain
Wistar Rats
Creatinine
Weights and Measures
Control Groups
Drinking Water
Liver Cirrhosis
Young Adult
Water

Keywords

  • Afzal
  • Alanine aminotransferase
  • Aspartate aminotransferase
  • Creatinine
  • Histopathological alterations
  • Kidney toxicity
  • Liver toxicity
  • Oman
  • Smokeless tobacco products (STPs)
  • Urea

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Liver and kidney toxicity induced by Afzal smokeless tobacco product in Oman. / Al-Mukhaini, Nawal; Ba-Omar, Taher; Eltayeb, Elsadig; Al-Shihi, Aisha; Al-Riyami, Nafila; Al-Belushi, Jamila; Al-Adawi, Kawthar.

In: Tissue and Cell, 31.08.2016.

Research output: Contribution to journalArticle

@article{04acb0957c494417a897ab7d286aac8a,
title = "Liver and kidney toxicity induced by Afzal smokeless tobacco product in Oman",
abstract = "Afzal, the common smokeless tobacco product (STP) in Oman, is believed to contain toxins that may impair the function of some organs such as liver and kidney. An aqueous extract from Afzal was added to drinking water to be administrated orally to Wistar albino rats (n = 72) young and adult from both genders weighing between 60-80. g and 150-240. g respectively for 8 weeks. Animals were divided into three groups: control (distilled water instead of Afzal extract), low-dose (3. mg. nicotine/kg. body. weight/day) and high-dose (6. mg. nicotine/kg. body. weight/day). The animals were euthanized and their blood, liver and kidney were collected for biochemical and histopathological investigations. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were assayed for the liver function, while blood urea nitrogen (BUN) and creatinine (CRT) were assayed for the kidney function. The results showed a significant increase in the ALT, AST, BUN and CRT levels (P <. 0.05) in both Afzal-treated groups (low and high doses) compared with the control. Histopathological findings revealed the initial but seem to be serious degenerative alterations of periportal fibrosis in liver and edematous and calcified changes in renal glomerulus among Afzal-treated groups. Additionally, the weight gain of the Afzal-treated groups was lower than the control group. Our findings show that the exposure of Wistar rats to the Afzal extract has the potentials of causing decreased weight gain and dose-dependent functional and structural damage to the biochemical and histological profiles of liver and kidney as well as serious biochemical effects.",
keywords = "Afzal, Alanine aminotransferase, Aspartate aminotransferase, Creatinine, Histopathological alterations, Kidney toxicity, Liver toxicity, Oman, Smokeless tobacco products (STPs), Urea",
author = "Nawal Al-Mukhaini and Taher Ba-Omar and Elsadig Eltayeb and Aisha Al-Shihi and Nafila Al-Riyami and Jamila Al-Belushi and Kawthar Al-Adawi",
year = "2016",
month = "8",
day = "31",
doi = "10.1016/j.tice.2017.01.008",
language = "English",
journal = "Tissue and Cell",
issn = "0040-8166",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Liver and kidney toxicity induced by Afzal smokeless tobacco product in Oman

AU - Al-Mukhaini, Nawal

AU - Ba-Omar, Taher

AU - Eltayeb, Elsadig

AU - Al-Shihi, Aisha

AU - Al-Riyami, Nafila

AU - Al-Belushi, Jamila

AU - Al-Adawi, Kawthar

PY - 2016/8/31

Y1 - 2016/8/31

N2 - Afzal, the common smokeless tobacco product (STP) in Oman, is believed to contain toxins that may impair the function of some organs such as liver and kidney. An aqueous extract from Afzal was added to drinking water to be administrated orally to Wistar albino rats (n = 72) young and adult from both genders weighing between 60-80. g and 150-240. g respectively for 8 weeks. Animals were divided into three groups: control (distilled water instead of Afzal extract), low-dose (3. mg. nicotine/kg. body. weight/day) and high-dose (6. mg. nicotine/kg. body. weight/day). The animals were euthanized and their blood, liver and kidney were collected for biochemical and histopathological investigations. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were assayed for the liver function, while blood urea nitrogen (BUN) and creatinine (CRT) were assayed for the kidney function. The results showed a significant increase in the ALT, AST, BUN and CRT levels (P <. 0.05) in both Afzal-treated groups (low and high doses) compared with the control. Histopathological findings revealed the initial but seem to be serious degenerative alterations of periportal fibrosis in liver and edematous and calcified changes in renal glomerulus among Afzal-treated groups. Additionally, the weight gain of the Afzal-treated groups was lower than the control group. Our findings show that the exposure of Wistar rats to the Afzal extract has the potentials of causing decreased weight gain and dose-dependent functional and structural damage to the biochemical and histological profiles of liver and kidney as well as serious biochemical effects.

AB - Afzal, the common smokeless tobacco product (STP) in Oman, is believed to contain toxins that may impair the function of some organs such as liver and kidney. An aqueous extract from Afzal was added to drinking water to be administrated orally to Wistar albino rats (n = 72) young and adult from both genders weighing between 60-80. g and 150-240. g respectively for 8 weeks. Animals were divided into three groups: control (distilled water instead of Afzal extract), low-dose (3. mg. nicotine/kg. body. weight/day) and high-dose (6. mg. nicotine/kg. body. weight/day). The animals were euthanized and their blood, liver and kidney were collected for biochemical and histopathological investigations. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were assayed for the liver function, while blood urea nitrogen (BUN) and creatinine (CRT) were assayed for the kidney function. The results showed a significant increase in the ALT, AST, BUN and CRT levels (P <. 0.05) in both Afzal-treated groups (low and high doses) compared with the control. Histopathological findings revealed the initial but seem to be serious degenerative alterations of periportal fibrosis in liver and edematous and calcified changes in renal glomerulus among Afzal-treated groups. Additionally, the weight gain of the Afzal-treated groups was lower than the control group. Our findings show that the exposure of Wistar rats to the Afzal extract has the potentials of causing decreased weight gain and dose-dependent functional and structural damage to the biochemical and histological profiles of liver and kidney as well as serious biochemical effects.

KW - Afzal

KW - Alanine aminotransferase

KW - Aspartate aminotransferase

KW - Creatinine

KW - Histopathological alterations

KW - Kidney toxicity

KW - Liver toxicity

KW - Oman

KW - Smokeless tobacco products (STPs)

KW - Urea

UR - http://www.scopus.com/inward/record.url?scp=85013078193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013078193&partnerID=8YFLogxK

U2 - 10.1016/j.tice.2017.01.008

DO - 10.1016/j.tice.2017.01.008

M3 - Article

C2 - 28238347

AN - SCOPUS:85013078193

JO - Tissue and Cell

JF - Tissue and Cell

SN - 0040-8166

ER -